International Endovascular Corporation

Advancing Next-Generation Vascular Technologies

International Endovascular Corporation (IEVC) is focused on acquiring, developing, and commercializing innovative technologies for the treatment of vascular disease.

The company combines experienced leadership, capital-efficient operations, and established technical infrastructure to selectively commercialize differentiated, clinically validated, medical device platforms.

Our flagship product, the DABRA™ Laser System addresses complex peripheral artery disease through minimally invasive plaque modification and vessel preparation. Utilizing innovative excimer laser and catheter technology, DABRA is engineered to cross and treat a wide range of lesion morphologies while minimizing vessel trauma and reducing the risk of distal embolization.